Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
JMIR Mhealth and Uhealth|December 2, 2025
Exploring Age-Related Patterns in Smartphone Keystroke Dynamics Considering Temporal Variability: Cross-Sectional Study With AI-Based AnalysisJunhyung Moon, Yu Lim Huh, Hee Young Cho, et al.
Journal of Biomedical Science|October 16, 2023
Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challengesHara Kang, Yun Ji Ga, Soo Hyun Kim, et al.
AAPS Pharmscitech|September 24, 2024
Development and Characterization of Olaparib-Loaded Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Pharmaceutical ApplicationsYuseon Shin, Mikyung Kim, Chaeyeon Kim, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2025
Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinomaChaeyeon Kim, Mina Han, Gamin Kim, et al.
International Journal of Molecular Sciences|January 11, 2024
Systemic Treatment with Fas-Blocking Peptide Attenuates Apoptosis in Brain IschemiaSungeun Chung, Yujong Yi, Irfan Ullah, et al.
Acta Biomaterialia|April 6, 2019
Graphene oxide substrates with N-cadherin stimulates neuronal growth and intracellular transportEllen C Qin, Mikhail E Kandel, Evangelos Liamas, et al.
Current Pharmaceutical Biotechnology|November 27, 2024
Gossypetin Alleviates DSS-induced Colitis by Regulating COX2 and ROS-JNK SignalingHyeonjin Kim, Eungyung Kim, Lei Ma, et al.
Cancer Research and Treatment|January 30, 2026
Circulating Tumor Cell-based Molecular Responses Stratify EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung CancerSeoyoung Lee, Chaeyeon Kim, Chang Gon Kim, et al.
Journal of the American Chemical Society|October 23, 2025
Turing-Type Catalytic 2D-Metal Nanomesh Inside Silica-Bilayer for Multicomponent Reaction ControlYu-Rim Hong, Nitee Kumari, Ankur Maji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell CarcinomaChang Gon Kim, Min Hee Hong, Dahee Kim, et al.
Pageof 2